Cargando…

Markers for obese and non-obese Type 2 diabetes identified using whole blood metabolomics

Definitive differences in blood metabolite profiles between obese and non-obese Type 2 diabetes (T2D) have not been established. We performed an LC–MS-based non-targeted metabolomic analysis of whole blood samples collected from subjects classified into 4 types, based on the presence or absence of o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teruya, Takayuki, Sunagawa, Sumito, Mori, Ayaka, Masuzaki, Hiroaki, Yanagida, Mitsuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922320/ https://www.ncbi.nlm.nih.gov/pubmed/36774491 http://dx.doi.org/10.1038/s41598-023-29619-4

Ejemplares similares

Reply to Pan et al.: Whole blood metabolome analysis combined with comprehensive frailty assessment
por: Kameda, Masahiro, et al.
Publicado: (2021)

Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites
por: Teruya, Takayuki, et al.
Publicado: (2021)

Whole Blood Metabolomics in Aging Research
por: Kondoh, Hiroshi, et al.
Publicado: (2020)

Frailty markers comprise blood metabolites involved in antioxidation, cognition, and mobility
por: Kameda, Masahiro, et al.
Publicado: (2020)

Metabolomics of human fasting: new insights about old questions
por: Kondoh, Hiroshi, et al.
Publicado: (2020)

Diverse metabolic reactions activated during 58-hr fasting are revealed by non-targeted metabolomic analysis of human blood
por: Teruya, Takayuki, et al.
Publicado: (2019)

Human age-declined saliva metabolic markers determined by LC–MS
por: Teruya, Takayuki, et al.
Publicado: (2021)

Aging markers in human urine: A comprehensive, non‐targeted LC‐MS study
por: Teruya, Takayuki, et al.
Publicado: (2020)

Reduced uremic metabolites are prominent feature of sarcopenia, distinct from antioxidative markers for frailty
por: Kameda, Masahiro, et al.
Publicado: (2021)

Reply to Zheng et al.: Clinical metabolomics: Detailed analysis by nontargeted method is complementary to large-scale studies
por: Kondoh, Hiroshi, et al.
Publicado: (2022)

Genomics and Metabolomics in Obesity and Type 2 Diabetes
por: Kretowski, Adam, et al.
Publicado: (2016)

Identification of Genes Affecting the Toxicity of Anti-Cancer Drug Bortezomib by Genome-Wide Screening in S. pombe
por: Takeda, Kojiro, et al.
Publicado: (2011)

Metabolomic analyses for atherosclerosis, diabetes, and obesity
por: Du, Fuyong, et al.
Publicado: (2013)

Nutritional genomics and metabolomics in obesity and type 2 diabetes
por: Hu, Frank B, et al.
Publicado: (2014)

S-Adenosylmethionine Synthetase Is Required for Cell Growth, Maintenance of G0 Phase, and Termination of Quiescence in Fission Yeast
por: Hayashi, Takeshi, et al.
Publicado: (2018)

Brown rice‐specific γ‐oryzanol as a promising prophylactic avenue to protect against diabetes mellitus and obesity in humans
por: Masuzaki, Hiroaki, et al.
Publicado: (2018)

Whole-Genome Sequencing of Suppressor DNA Mixtures Identifies Pathways That Compensate for Chromosome Segregation Defects in Schizosaccharomyces pombe
por: Xu, Xingya, et al.
Publicado: (2018)

Genetic defects in SAPK signalling, chromatin regulation, vesicle transport and CoA-related lipid metabolism are rescued by rapamycin in fission yeast
por: Sajiki, Kenichi, et al.
Publicado: (2018)

Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity
por: Ghosh, Sujoy, et al.
Publicado: (2010)

Pre-diagnostic biomarkers of type 2 diabetes identified in the UAE’s obese national population using targeted metabolomics
por: Fikri, Asma M., et al.
Publicado: (2020)

Metabolomic Profiles of Nonobese and Obese Women With Gestational Diabetes
por: Sormunen-Harju, Heidi, et al.
Publicado: (2023)

Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity
por: Sasaki, Akira, et al.
Publicado: (2021)

The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity
por: Nakata, Takaya, et al.
Publicado: (2016)

Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study
por: Sunagawa, Sumito, et al.
Publicado: (2018)

Complex effects of whole body cryostimulation on hematological markers in patients with obesity
por: Wyrostek, Joanna, et al.
Publicado: (2021)

Mass Spectrometry-Based Metabolomics Analysis of Obese Patients’ Blood Plasma
por: Lokhov, Petr G., et al.
Publicado: (2020)

The metabolome profiling of obese and non-obese individuals: Metabolically healthy obese and unhealthy non-obese paradox
por: Chashmniam, Saeed, et al.
Publicado: (2020)

Association of ABO blood types and novel obesity markers in healthy adolescents
por: Siddiqui, Nazeem Ishrat, et al.
Publicado: (2019)

Comparison of the microbiome, metabolome, and lipidome of obese and non-obese horses
por: Coleman, Michelle C., et al.
Publicado: (2019)

Metabolomic Analysis of Fission Yeast at the Onset of Nitrogen Starvation
por: Sajiki, Kenichi, et al.
Publicado: (2013)

Consumption and acceptability of whole grain staples for lowering markers of diabetes risk among overweight and obese Tanzanian adults
por: Muhihi, Alfa, et al.
Publicado: (2013)

Mechanisms of expression and translocation of major fission yeast glucose transporters regulated by CaMKK/phosphatases, nuclear shuttling, and TOR
por: Saitoh, Shigeaki, et al.
Publicado: (2015)

Visceral Adipose Tissue Displays Unique Metabolomic Fingerprints in Obesity, Pre-Diabetes and Type 2 Diabetes
por: Morais, Tiago, et al.
Publicado: (2021)

A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes
por: Park, Seokjae, et al.
Publicado: (2015)

Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients
por: Hansen, Dominique, et al.
Publicado: (2010)

Salivary inflammatory markers and microbiome in normoglycemic lean and obese children compared to obese children with type 2 diabetes
por: Janem, Waleed F., et al.
Publicado: (2017)

Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion
por: Al-Nesf, Amna, et al.
Publicado: (2022)

Genetic and Metabolomic Dissection of the Ergothioneine and Selenoneine Biosynthetic Pathway in the Fission Yeast, S. pombe, and Construction of an Overproduction System
por: Pluskal, Tomáš, et al.
Publicado: (2014)

Investigating Potential Mechanisms of Obesity by Metabolomics
por: Xie, Baogang, et al.
Publicado: (2012)

Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity – diabetes?
por: Pontiroli, Antonio E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hhvibotvuu3adm87us1po6siov